Breathe Well Live Well
|
Glenmark, Aurobindo get US nod for asthma treatment drug
Moneycontrol.com … has received final approval from US Food and Drugs Administration for its abbreviated new drug application (ANDA) to market Montelukast Sodium tablets in 10 mg strength, which are used for the treatment for prophylaxis and chronic treatment of asthma. |
View full post on asthma – Google News
 MedPage Today |
FDA approves generic versions of asthma, allergy drug
Drug Store News SILVER SPRING, Md. — The Food and Drug Administration has approved several generic versions of a drug used to treat asthma and allergies, the agency said Friday. The FDA announced the approval of montelukast sodium, a drug indicated for controlling … First generic versions of Singulair receive FDA approval for treatment of … Generic Singulair Approved Teva asthma, allergy drug approved by FDA |
View full post on asthma – Google News
 Business Today |
Glenmark hits 52-week high on US nod for asthma generic drug
Business Today Shares of Glenmark Pharma hit a fresh 52-week high on Monday after the company received approval from the US health regulator to manufacture and market generic montelukast sodium tablets used for treating asthma and allergies . Glenmark said it would … |
View full post on asthma – Google News
Business Today |
Aurobindo gets USFDA nod for asthma drug
Moneycontrol.com Mon, Aug 06, 2012 at 16:09. Aurobindo gets USFDA nod for asthma drug. Aurobindo Pharma today said it has received the final approval from USFDA to manufacture and market montelukast sodium tablets used for treating asthma and allergies. Source: PTI … Glenmark hits 52-week high on US nod for asthma generic drug Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drug Aurobindo gets US FDA nod for anti-asthma, chewable tablets |
View full post on asthma – Google News
 Zee News |
Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drug
Economic Times NEW DELHI: Drug firms Aurobindo Pharma and Glenmark today said they have received approval from the US health regulator to manufacture and market generic montelukast sodium tablets used for treating asthma and allergies. Both the companies said … Pharma cos set to gain from US nod for asthma drug |
View full post on asthma – Google News
|
Glenmark gets final US FDA nod for asthma treatment drug
Moneycontrol.com … has received final approval from US Food and Drugs Administration for its abbreviated new drug application (ANDA) to market Montelukast Sodium tablets in 10 mg strength, which are used for the treatment for prophylaxis and chronic treatment of asthma. |
View full post on asthma – Google News
|
Pharma cos set to gain from US nod for asthma drug
Business Standard New Delhi, Aug 5 (PTI) Indian drug makers, including Aurobindo and Glenmark, are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market. Last week the US Food and … |
View full post on asthma – Google News
|
New drug 'stops common cold asthma deaths'
Ripon Today The news is based solely on a press release, which gives some information about the findings of an early-stage clinical trial of a new, unlicensed asthma drug called SNG001. The press release describes research that was conducted in a total of 134 … |
View full post on asthma – Google News
MedPage Today |
FDA Greenlights Asthma Drug Generics
MedPage Today SILVER SPRING, Md. — Generic forms of the popular asthma drug montelukast sodium (Singulair) produced by 10 manufacturers have won FDA approval, the agency announced. Montelukast is a leukotriene receptor antagonist and, unlike other most other … FDA approves generic versions of Singulair FDA approves first generic versions of Singulair to treat asthma, allergies First Generic Versions of Singulair Approved |
View full post on asthma – Google News
|
Watson gets FDA approval for generic asthma drug
Businessweek PARSIPPANY, N.J. (AP) — Generic drugmaker Watson Pharmaceuticals Inc. said Wednesday it received U.S. approval for its generic version of Pulmicort, an inhalable drug used to treat cough and breathing problems caused by asthma and lung disease. FDA approves Watson asthma generic Watson's Generic Version of Pulmicort RESPULES® Receives FDA Approval |
View full post on asthma – Google News